Optimer Pharmaceuticals Inc. (OPTR) announced Wednesday morning that its Chairman, Dr. Henry McKinnell, was appointed as Chief Executive Officer. The Board also announced that it has commenced a process to explore a full range of strategic alternatives.
Optimer Pharmaceuticals gapped open higher Wednesday and climbed in early trade, but settled into a narrow range for the majority of the session. The stock closed up by 1.41 at $12.13 on the highest volume of the year. Optimer broke out to over a 4-month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.